Absorption, disposition, metabolism, and excretion of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, in rats

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 12, 2014-12 ,pp. : 881-888

Govi-Verlag

Access to resources Recommend Favorite

The effect of mirabegron, a potent and selective β₃-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol

By Krauwinkel Walter   Dickinson James   Schaddelee Marloes   Meijer John   Tretter Reiner   Wetering Jeroen   Strabach Gregory   Gelderen Marcel  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 39, Iss. 1, 2014-03 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite

Clinically relevant drug–drug interactions between antiretrovirals and antifungals

By Vadlapatla Ramya Krishna   Patel Mitesh   Paturi Durga K   Pal Dhananjay   Mitra Ashim K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 561-580

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450 Part 3: Impact of Drug‐Drug Interactions

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 1, 2009-03 ,pp. : 55-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 305-314

John Wiley & Sons Inc

Access to resources Recommend Favorite